{"hands_on_practices": [{"introduction": "The activation of many signaling pathways begins with a critical event at the cell surface. This exercise focuses on Receptor Tyrosine Kinases (RTKs), a crucial class of receptors involved in processes like cell growth and differentiation. By examining what happens when a key step in their activation sequence—dimerization—is blocked, we can solidify our understanding of why each step in this molecular choreography is essential for signal transmission. [@problem_id:2300977]", "problem": "In a cell biology laboratory, researchers are studying a specific signaling pathway crucial for cell proliferation. This pathway is initiated when a specific growth factor binds to a Receptor Tyrosine Kinase (RTK). The canonical activation sequence for this RTK is as follows: the binding of the growth factor to two separate receptor monomers induces them to form a dimer; this dimerization activates the intracellular kinase domain of each monomer, leading to cross-phosphorylation (autophosphorylation) of tyrosine residues on the opposing monomer's cytoplasmic tail. These phosphorylated tyrosines then serve as docking sites for specific intracellular relay proteins, which, upon binding, become activated and propagate the signal.\n\nThe researchers introduce a genetic modification into the cell line, creating a mutation in the RTK gene. This specific mutation does not affect the growth factor binding site, nor the intrinsic kinase activity of the cytoplasmic domain. However, it alters the transmembrane domain in such a way that it completely prevents the two receptor monomers from associating into a dimer, even in the presence of a saturating concentration of the growth factor.\n\nGiven this specific mutation, which of the following statements describes the most immediate and direct consequence for the signaling pathway when the growth factor is introduced to these cells?\n\nA. The receptor will fail to undergo autophosphorylation.\n\nB. The growth factor will be unable to bind to the individual receptor monomers.\n\nC. An associated G protein will remain in its inactive, GDP-bound state.\n\nD. Intracellular relay proteins will bind to the receptor but will not become activated.\n\nE. The kinase domains of the receptor will be constitutively active, leading to uncontrolled cell signaling.", "solution": "Principle of RTK activation: In canonical receptor tyrosine kinase signaling, a growth factor binds two receptor monomers, induces dimerization, and thereby activates the intracellular kinase domains. Activated kinase domains perform trans-autophosphorylation, meaning each monomer phosphorylates tyrosine residues on the cytoplasmic tail of the other monomer. These phosphotyrosines create docking sites (recognized by SH2 or PTB domains) for specific intracellular relay proteins, whose binding is contingent on the presence of phosphorylated tyrosines; upon docking, these relay proteins become activated and propagate downstream signaling.\n\nGiven mutation and its effects: The mutation leaves the ligand-binding site intact and does not impair the intrinsic catalytic ability of the kinase domain, but it prevents dimerization. Because ligand binding alone without dimerization is insufficient to activate most RTKs, the absence of dimerization blocks the conformational activation that enables trans-autophosphorylation and also removes the partner substrate required for phosphorylation in trans. Therefore, no phosphotyrosines are generated on the receptor tails.\n\nImmediate mechanistic consequence: Without dimerization, the kinase domains cannot undergo ligand-induced activation and cannot perform trans-autophosphorylation of tyrosines. Since phosphotyrosines are not formed, relay proteins cannot dock, and downstream events such as activation of small GTPases (for example, Ras via Grb2 and SOS) do not occur. However, among the listed options, the earliest direct step that fails upon growth factor addition is autophosphorylation of the receptor.\n\nEvaluation of options:\n- A. The receptor will fail to undergo autophosphorylation. This is the immediate blocked step because dimerization is required for trans-autophosphorylation.\n- B. Incorrect because the growth factor binding site is unaffected; ligand can bind monomeric receptors.\n- C. While downstream small GTPases would indeed remain GDP-bound due to lack of upstream activation, this is not the most immediate consequence at the receptor level and conflates RTKs with GPCR mechanisms.\n- D. Incorrect because relay proteins require phosphotyrosines to bind; without autophosphorylation they do not bind at all.\n- E. Incorrect because the mutation prevents dimerization-dependent activation; it does not cause constitutive activity.\n\nTherefore, the most immediate and direct consequence is failure of receptor autophosphorylation.", "answer": "$$\\boxed{A}$$", "id": "2300977"}, {"introduction": "Cell signaling does not occur in a vacuum; individual pathways are integrated into complex networks that maintain physiological balance, or homeostasis. This problem challenges you to scale up from a single cell to a multi-tiered endocrine axis, a classic example of long-distance signaling. You will predict how a specific genetic mutation creates a disruption that ripples through the entire system, revealing the power and logic of negative feedback in maintaining stability. [@problem_id:2300995]", "problem": "Consider a hypothetical three-tiered endocrine axis responsible for regulating a key metabolic process. The axis is organized hierarchically as follows:\n\n1.  The hypothalamus secretes Hypothalamic Releasing Factor (HRF).\n2.  HRF travels to the anterior pituitary gland, stimulating it to secrete Pituitary Tropic Hormone (PTH).\n3.  PTH travels through the bloodstream to a peripheral endocrine gland, stimulating it to synthesize and secrete Glandular Effector Hormone (GEH).\n4.  GEH acts on various target tissues throughout the body to produce a physiological response.\n5.  In a crucial negative feedback loop, GEH inhibits the secretion of both HRF from the hypothalamus and PTH from the anterior pituitary.\n\nNow, imagine an individual develops a rare genetic condition involving a gain-of-function mutation in the gene that codes for the PTH receptor on the peripheral endocrine gland. This mutation causes the PTH receptor to become constitutively active, meaning it signals continuously as if it were constantly bound by PTH, regardless of the actual concentration of PTH in the blood.\n\nAssuming the system has reached a new homeostatic steady state, which of the following options best describes the expected plasma concentrations of HRF, PTH, and GEH in this individual compared to a healthy person?\n\nA. HRF: High, PTH: High, GEH: High\n\nB. HRF: Low, PTH: Low, GEH: High\n\nC. HRF: Low, PTH: Low, GEH: Low\n\nD. HRF: High, PTH: Low, GEH: High\n\nE. HRF: Normal, PTH: Normal, GEH: High", "solution": "Let $H$ denote hypothalamic releasing factor (HRF), $P$ denote pituitary tropic hormone (PTH), and $G$ denote glandular effector hormone (GEH). Let $R$ denote activation of the PTH receptor on the peripheral endocrine gland.\n\nIn the normal axis, the causal relations are:\n1. Hypothalamus to pituitary: $P$ increases with $H$, so $P=p(H)$ with $p^{\\prime}(H)>0$.\n2. Pituitary to gland: receptor activation is an increasing function of $P$, so $R=f(P)$ with $f^{\\prime}(P)>0$.\n3. Gland output: $G$ increases with $R$, so $G=g(R)$ with $g^{\\prime}(R)>0$.\n4. Negative feedback by $G$: $G$ inhibits both $H$ and $P$. A convenient representation is\n$$\nH=H_{\\text{basal}}-\\phi(G), \\quad \\phi^{\\prime}(G)>0,\n$$\n$$\nP=p(H)-\\psi(G), \\quad \\psi^{\\prime}(G)>0,\n$$\nwhich encodes direct inhibition of the pituitary by $G$ in addition to the hypothalamic effect.\n\nUnder the gain-of-function mutation, the PTH receptor is constitutively active. This makes receptor activation independent of $P$, so\n$$\nR=R_{\\ast},\n$$\nwith $R_{\\ast}$ elevated relative to the normal range. Because $G=g(R)$ with $g^{\\prime}>0$, this yields\n$$\nG=g(R_{\\ast}),\n$$\nwhich is elevated compared to normal. Elevated $G$ imposes negative feedback on both hypothalamus and pituitary, so\n$$\nH=H_{\\text{basal}}-\\phi(G)\n$$\nis reduced, and\n$$\nP=p(H)-\\psi(G)\n$$\nis also reduced, since $H$ is reduced and $G$ directly inhibits $P$.\n\nAt the new steady state, therefore, $G$ is high due to ligand-independent $R$, and both $H$ and $P$ are low due to the negative feedback from elevated $G$.\n\nThis pattern corresponds to HRF low, PTH low, GEH high, which matches option B.", "answer": "$$\\boxed{B}$$", "id": "2300995"}, {"introduction": "How far can a local signal travel, and what determines its effective range in a tissue? This practice moves into the quantitative realm to explore how paracrine signals, known as morphogens, create spatial patterns during development. By using a simple mathematical model, you will discover how physical parameters like the diffusion rate ($D$) and the degradation rate ($k$) directly control the reach of a signal, providing a powerful framework for understanding tissue organization. [@problem_id:2301002]", "problem": "During embryonic development, the spatial patterning of tissues is often orchestrated by gradients of signaling molecules called morphogens. Consider a simplified one-dimensional model of a developing tissue stripe. A localized source of a specific morphogen is positioned at one end of the tissue ($x=0$), maintaining a constant concentration $C_0$. The morphogen diffuses away from the source into the tissue and is simultaneously cleared by enzymatic degradation.\n\nThe steady-state concentration profile of the morphogen, $C(x)$, is determined by a balance between its diffusion, characterized by a diffusion coefficient $D$, and its degradation, which is modeled as a first-order process with a rate constant $k$. Cells within the tissue can sense the local morphogen concentration and activate a specific developmental program only if the concentration exceeds a critical threshold, $C_{th}$, where $C_{th} < C_0$. The effective signaling radius, $x_{eff}$, is defined as the maximum distance from the source at which the morphogen concentration is precisely equal to this threshold, i.e., $C(x_{eff}) = C_{th}$.\n\nNow, consider a genetic mutation that alters the properties of the extracellular environment. This mutation has two independent effects:\n1. It alters the composition of the extracellular matrix, causing the morphogen's diffusion coefficient to change to a new value, $D_{mut} = \\alpha D$, where $\\alpha$ is a dimensionless constant.\n2. It modifies the structure of the degrading enzyme, causing its kinetic rate constant to change to a new value, $k_{mut} = \\beta k$, where $\\beta$ is a dimensionless constant.\n\nAssuming the source concentration $C_0$ and the cellular threshold concentration $C_{th}$ are unaffected by the mutation, determine the ratio of the new effective signaling radius under the mutation, $x_{mut}$, to the original \"wild-type\" signaling radius, $x_{wild}$. Express your answer as a symbolic expression in terms of $\\alpha$ and $\\beta$.", "solution": "At steady state in one spatial dimension with diffusion and first-order degradation, the morphogen concentration satisfies the ordinary differential equation derived from Fick’s law and linear decay:\n$$\nD \\frac{d^{2}C}{dx^{2}} - k C = 0.\n$$\nThe general solution is\n$$\nC(x) = A \\exp\\!\\left(x\\sqrt{\\frac{k}{D}}\\right) + B \\exp\\!\\left(-x\\sqrt{\\frac{k}{D}}\\right).\n$$\nImposing boundedness as $x \\to \\infty$ requires $A=0$. The boundary condition at the source gives $C(0)=C_{0}$, hence $B=C_{0}$, so\n$$\nC(x) = C_{0}\\,\\exp\\!\\left(-x\\sqrt{\\frac{k}{D}}\\right).\n$$\nThe effective signaling radius $x_{eff}$ is defined by $C(x_{eff})=C_{th}$. Thus,\n$$\nC_{th} = C_{0}\\,\\exp\\!\\left(-x_{eff}\\sqrt{\\frac{k}{D}}\\right),\n$$\nwhich yields, after taking the natural logarithm and solving for $x_{eff}$,\n$$\nx_{eff} = \\sqrt{\\frac{D}{k}}\\,\\ln\\!\\left(\\frac{C_{0}}{C_{th}}\\right).\n$$\nFor the wild type,\n$$\nx_{wild} = \\sqrt{\\frac{D}{k}}\\,\\ln\\!\\left(\\frac{C_{0}}{C_{th}}\\right).\n$$\nUnder the mutation, $D_{mut}=\\alpha D$ and $k_{mut}=\\beta k$, while $C_{0}$ and $C_{th}$ are unchanged, so\n$$\nx_{mut} = \\sqrt{\\frac{D_{mut}}{k_{mut}}}\\,\\ln\\!\\left(\\frac{C_{0}}{C_{th}}\\right)\n= \\sqrt{\\frac{\\alpha D}{\\beta k}}\\,\\ln\\!\\left(\\frac{C_{0}}{C_{th}}\\right)\n= \\sqrt{\\frac{\\alpha}{\\beta}}\\,\\sqrt{\\frac{D}{k}}\\,\\ln\\!\\left(\\frac{C_{0}}{C_{th}}\\right)\n= \\sqrt{\\frac{\\alpha}{\\beta}}\\,x_{wild}.\n$$\nTherefore, the ratio of the mutant to wild-type effective signaling radii is\n$$\n\\frac{x_{mut}}{x_{wild}} = \\sqrt{\\frac{\\alpha}{\\beta}}.\n$$", "answer": "$$\\boxed{\\sqrt{\\frac{\\alpha}{\\beta}}}$$", "id": "2301002"}]}